Increased expression of gallbladder cholecystokinin: a receptor in prairie dogs fed a high-cholesterol diet and its dissociation with decreased contractility in response to cholecystokinin.
A series of our studies have shown that formation of cholesterol-supersaturated bile in patients with cholesterol gallstone disease is causatively related to decreased gallbladder contractility and mucin hypersecretion by the gallbladder. Supersaturated bile may modify the composition of gallbladder membranes so that the transduction of smooth muscle regulatory signals is impaired, and it may enhance the inflammation-induced mucin secretion by the gallbladder. To achieve a better understanding of the mechanism by which supersaturated bile impairs the contractility, we studied changes in the expression levels of gallbladder cholecystokinin (CCK-A) receptor messenger ribonucleic acid (mRNA) in prairie dogs fed a high-cholesterol diet. Levels of pathobiological determinants in arachidonate metabolism which are important for mucin secretion were also measured in their bile. Adult male prairie dogs were randomly assigned to receive either a semisynthetic diet (SSD) or an SSD plus 1.2% cholesterol (a high-cholesterol diet) for 2-, 4-, and 6-week periods. The contractile force in response to CCK-octapeptide (CCK-8) was measured by using gallbladder muscle strips. The mRNA levels of the CCK-A receptor were determined by reverse-transcription polymerase chain reaction (RT-PCR). Parallel to the increase in the cholesterol saturation index, the contractile responses to CCK-8 decreased in the animals fed a high-cholesterol diet for 4 weeks and markedly decreased in the animals with gallstone formation. However, in contrast to the decreased contractility, the steady-state mRNA levels of the gallbladder CCK-A receptor were significantly increased in the animals fed a high-cholesterol diet in comparison with the corresponding control animals. In the bile, a high-cholesterol diet caused an increase in the proportion of arachidonyl-phosphatidylcholine species, where phospholipase A(2) activity, prostaglandin E(2), and mucin concentrations were increased parallel to the feeding period. Up-regulation of the CCK-A receptor mRNA in the gallbladder of animals fed a high-cholesterol diet associated with decreased contractility may be due to an impairment of CCK signaling related to increased membrane cholesterol contents and its related reaction of biological compensation in order to increase the receptor concentration. The results of the present study suggest that in prairie dogs fed a high-cholesterol diet both a decrease in gallbladder contractility related to impairment of CCK signaling and phospholipase A(2) (PLA(2))-induced mucosal inflammation in the gallbladder with associated biliary alterations favoring cholesterol crystal formation pathogenetically contribute to the formation of cholesterol gallstones.
Kano
Masahito
M
Department of Gastroenterology Surgery, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan.
Shoda
Junichi
J
Satoh
Susumu
S
Kobayashi
Masakazu
M
Matsuzaki
Yasushi
Y
Abei
Masato
M
Tanaka
Naomi
N
D000818:Animals; D016718:Arachidonic Acid / Q000032:analysis; D001646:Bile / Q000737:chemistry / Q000378:metabolism; D015152:Blotting, Northern; D001835:Body Weight; D002769:Cholelithiasis / Q000209:etiology* / Q000503:physiopathology; D002784:Cholesterol / Q000032:analysis / Q000097:blood / Q000737:chemistry; D002790:Cholesterol 7-alpha-Hydroxylase / Q000378:metabolism; D002791:Cholesterol, Dietary / Q000008:administration & dosage*; D003460:Crystallization; D015232:Dinoprostone / Q000378:metabolism; D004195:Disease Models, Animal; D005227:Fatty Acids / Q000032:analysis; D005704:Gallbladder / Q000503:physiopathology*; D015870:Gene Expression; D006903:Hydroxymethylglutaryl CoA Reductases / Q000378:metabolism; D008055:Lipids / Q000032:analysis; D008099:Liver / Q000737:chemistry; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology; D009077:Mucins / Q000378:metabolism; D009119:Muscle Contraction / Q000187:drug effects*; D009132:Muscles / Q000187:drug effects / Q000503:physiopathology; D010713:Phosphatidylcholines / Q000032:analysis; D010741:Phospholipases A / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis; D043886:Receptor, Cholecystokinin A; D011949:Receptors, Cholecystokinin / Q000235:genetics / Q000502:physiology*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012589:Sciuridae; D012844:Sincalide / Q000494:pharmacology*
D002791:Cholesterol, Dietary; D005227:Fatty Acids; D008055:Lipids; D009077:Mucins; D010713:Phosphatidylcholines; D012333:RNA, Messenger; D043886:Receptor, Cholecystokinin A; D011949:Receptors, Cholecystokinin; D016718:Arachidonic Acid; D002784:Cholesterol; D006903:Hydroxymethylglutaryl CoA Reductases; D002790:Cholesterol 7-alpha-Hydroxylase; D010741:Phospholipases A; D015232:Dinoprostone; D012844:Sincalide